|
|
 |
|
Viewing report
|
|
|
|
Emerging Technologies: Stem Cells
Datamonitor, Nov 2011, Pages: 61
Stem cell therapies will play an increasingly important role in the underserved field of regenerative medicine, as preclinical discoveries are translated into the clinical setting and product candidates slowly progress through a diverse pipeline.
Features and benefits
- A full stem cell pipeline by each therapeutic category from preclinical stage to registration candidates.
- Provides an insight into key players, recent deals and developments.
Highlights
- Small and medium-sized research-led companies dominate the stem cells landscape, with a few large pharmaceutical companies beginning to invest in recent years. The stem cells sector is highly heterogeneous, consisting of different technology platforms, including embryonic and adult stem cells, applied in a wide range of therapy areas.
- Geron’s recent divestment in the sector highlights the several technical challenges associated with the application of stem cells in certain therapy areas, in particular, the central nervous system.
Your key questions answered
- Assess the key challenges and opportunities expected to shape the sector in the near term.
- Benchmark the competitive landscape within the stem cell sector, identifying the key pipeline candidates and most active disease areas of development.
|
|
|
|
